nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.072	0.126	CbGbCtD
Salbutamol—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0677	0.119	CbGbCtD
Salbutamol—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0677	0.119	CbGbCtD
Salbutamol—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0613	0.107	CbGbCtD
Salbutamol—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0613	0.107	CbGbCtD
Salbutamol—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0529	0.0925	CbGbCtD
Salbutamol—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0513	0.0898	CbGbCtD
Salbutamol—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0464	0.0812	CbGbCtD
Salbutamol—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0464	0.0812	CbGbCtD
Salbutamol—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0445	0.0779	CbGbCtD
Salbutamol—Clenbuterol—TNF—acquired immunodeficiency syndrome	0.00223	0.704	CrCbGaD
Salbutamol—Epinephrine—TNF—acquired immunodeficiency syndrome	0.000936	0.296	CrCbGaD
Salbutamol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000241	0.000566	CcSEcCtD
Salbutamol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.000565	CcSEcCtD
Salbutamol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00024	0.000565	CcSEcCtD
Salbutamol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00024	0.000564	CcSEcCtD
Salbutamol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.000564	CcSEcCtD
Salbutamol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000563	CcSEcCtD
Salbutamol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000562	CcSEcCtD
Salbutamol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000562	CcSEcCtD
Salbutamol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000562	CcSEcCtD
Salbutamol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000238	0.000561	CcSEcCtD
Salbutamol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.000561	CcSEcCtD
Salbutamol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.000559	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000237	0.000557	CcSEcCtD
Salbutamol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000237	0.000556	CcSEcCtD
Salbutamol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000236	0.000556	CcSEcCtD
Salbutamol—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000556	CcSEcCtD
Salbutamol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.000556	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000555	CcSEcCtD
Salbutamol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000555	CcSEcCtD
Salbutamol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000554	CcSEcCtD
Salbutamol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000235	0.000552	CcSEcCtD
Salbutamol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000235	0.000552	CcSEcCtD
Salbutamol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000551	CcSEcCtD
Salbutamol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.000551	CcSEcCtD
Salbutamol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00055	CcSEcCtD
Salbutamol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000549	CcSEcCtD
Salbutamol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.000548	CcSEcCtD
Salbutamol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.000548	CcSEcCtD
Salbutamol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.000548	CcSEcCtD
Salbutamol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000547	CcSEcCtD
Salbutamol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000547	CcSEcCtD
Salbutamol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000232	0.000546	CcSEcCtD
Salbutamol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000232	0.000546	CcSEcCtD
Salbutamol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000545	CcSEcCtD
Salbutamol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000545	CcSEcCtD
Salbutamol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000544	CcSEcCtD
Salbutamol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.000543	CcSEcCtD
Salbutamol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000542	CcSEcCtD
Salbutamol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000541	CcSEcCtD
Salbutamol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000541	CcSEcCtD
Salbutamol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000541	CcSEcCtD
Salbutamol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00054	CcSEcCtD
Salbutamol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000539	CcSEcCtD
Salbutamol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000229	0.000538	CcSEcCtD
Salbutamol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.000536	CcSEcCtD
Salbutamol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.000535	CcSEcCtD
Salbutamol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000533	CcSEcCtD
Salbutamol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000226	0.000532	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000531	CcSEcCtD
Salbutamol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000531	CcSEcCtD
Salbutamol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00053	CcSEcCtD
Salbutamol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000529	CcSEcCtD
Salbutamol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000529	CcSEcCtD
Salbutamol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000225	0.000529	CcSEcCtD
Salbutamol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000529	CcSEcCtD
Salbutamol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000224	0.000528	CcSEcCtD
Salbutamol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000527	CcSEcCtD
Salbutamol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000527	CcSEcCtD
Salbutamol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000526	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.000526	CcSEcCtD
Salbutamol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000223	0.000525	CcSEcCtD
Salbutamol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.000525	CcSEcCtD
Salbutamol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.000524	CcSEcCtD
Salbutamol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000524	CcSEcCtD
Salbutamol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000521	CcSEcCtD
Salbutamol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000521	CcSEcCtD
Salbutamol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000521	CcSEcCtD
Salbutamol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000222	0.000521	CcSEcCtD
Salbutamol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000221	0.000521	CcSEcCtD
Salbutamol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.00052	CcSEcCtD
Salbutamol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000221	0.00052	CcSEcCtD
Salbutamol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000519	CcSEcCtD
Salbutamol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000518	CcSEcCtD
Salbutamol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00022	0.000518	CcSEcCtD
Salbutamol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000516	CcSEcCtD
Salbutamol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000516	CcSEcCtD
Salbutamol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000516	CcSEcCtD
Salbutamol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000516	CcSEcCtD
Salbutamol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000515	CcSEcCtD
Salbutamol—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000514	CcSEcCtD
Salbutamol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000513	CcSEcCtD
Salbutamol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000512	CcSEcCtD
Salbutamol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000511	CcSEcCtD
Salbutamol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00051	CcSEcCtD
Salbutamol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000217	0.00051	CcSEcCtD
Salbutamol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000217	0.00051	CcSEcCtD
Salbutamol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000509	CcSEcCtD
Salbutamol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000216	0.000509	CcSEcCtD
Salbutamol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000216	0.000507	CcSEcCtD
Salbutamol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.000507	CcSEcCtD
Salbutamol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000505	CcSEcCtD
Salbutamol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000215	0.000505	CcSEcCtD
Salbutamol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000214	0.000504	CcSEcCtD
Salbutamol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000504	CcSEcCtD
Salbutamol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000504	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000503	CcSEcCtD
Salbutamol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000214	0.000503	CcSEcCtD
Salbutamol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000503	CcSEcCtD
Salbutamol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000214	0.000503	CcSEcCtD
Salbutamol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000502	CcSEcCtD
Salbutamol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000502	CcSEcCtD
Salbutamol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.000501	CcSEcCtD
Salbutamol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000213	0.0005	CcSEcCtD
Salbutamol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000213	0.0005	CcSEcCtD
Salbutamol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000499	CcSEcCtD
Salbutamol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000499	CcSEcCtD
Salbutamol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000498	CcSEcCtD
Salbutamol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000498	CcSEcCtD
Salbutamol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000211	0.000496	CcSEcCtD
Salbutamol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000211	0.000495	CcSEcCtD
Salbutamol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000495	CcSEcCtD
Salbutamol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000495	CcSEcCtD
Salbutamol—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000495	CcSEcCtD
Salbutamol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000209	0.000492	CcSEcCtD
Salbutamol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000492	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000491	CcSEcCtD
Salbutamol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000209	0.000491	CcSEcCtD
Salbutamol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.000491	CcSEcCtD
Salbutamol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000488	CcSEcCtD
Salbutamol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000487	CcSEcCtD
Salbutamol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000486	CcSEcCtD
Salbutamol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000485	CcSEcCtD
Salbutamol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000484	CcSEcCtD
Salbutamol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000484	CcSEcCtD
Salbutamol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000482	CcSEcCtD
Salbutamol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000482	CcSEcCtD
Salbutamol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000481	CcSEcCtD
Salbutamol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000481	CcSEcCtD
Salbutamol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000481	CcSEcCtD
Salbutamol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000479	CcSEcCtD
Salbutamol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000479	CcSEcCtD
Salbutamol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000477	CcSEcCtD
Salbutamol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.000475	CcSEcCtD
Salbutamol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000202	0.000475	CcSEcCtD
Salbutamol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000475	CcSEcCtD
Salbutamol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000475	CcSEcCtD
Salbutamol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000202	0.000474	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000473	CcSEcCtD
Salbutamol—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000472	CcSEcCtD
Salbutamol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000469	CcSEcCtD
Salbutamol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000469	CcSEcCtD
Salbutamol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000199	0.000467	CcSEcCtD
Salbutamol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000466	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000466	CcSEcCtD
Salbutamol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000465	CcSEcCtD
Salbutamol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000463	CcSEcCtD
Salbutamol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000463	CcSEcCtD
Salbutamol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000463	CcSEcCtD
Salbutamol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000463	CcSEcCtD
Salbutamol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000461	CcSEcCtD
Salbutamol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000461	CcSEcCtD
Salbutamol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000461	CcSEcCtD
Salbutamol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000461	CcSEcCtD
Salbutamol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000461	CcSEcCtD
Salbutamol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.000459	CcSEcCtD
Salbutamol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000457	CcSEcCtD
Salbutamol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000194	0.000456	CcSEcCtD
Salbutamol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000451	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000451	CcSEcCtD
Salbutamol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000449	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000448	CcSEcCtD
Salbutamol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000448	CcSEcCtD
Salbutamol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000447	CcSEcCtD
Salbutamol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000445	CcSEcCtD
Salbutamol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000444	CcSEcCtD
Salbutamol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000444	CcSEcCtD
Salbutamol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000444	CcSEcCtD
Salbutamol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000441	CcSEcCtD
Salbutamol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000441	CcSEcCtD
Salbutamol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000441	CcSEcCtD
Salbutamol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000441	CcSEcCtD
Salbutamol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00044	CcSEcCtD
Salbutamol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.000437	CcSEcCtD
Salbutamol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000437	CcSEcCtD
Salbutamol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.000437	CcSEcCtD
Salbutamol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000436	CcSEcCtD
Salbutamol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000434	CcSEcCtD
Salbutamol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000431	CcSEcCtD
Salbutamol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00043	CcSEcCtD
Salbutamol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.00043	CcSEcCtD
Salbutamol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000428	CcSEcCtD
Salbutamol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000428	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000427	CcSEcCtD
Salbutamol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000427	CcSEcCtD
Salbutamol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000427	CcSEcCtD
Salbutamol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000426	CcSEcCtD
Salbutamol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000426	CcSEcCtD
Salbutamol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000424	CcSEcCtD
Salbutamol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000423	CcSEcCtD
Salbutamol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000423	CcSEcCtD
Salbutamol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000418	CcSEcCtD
Salbutamol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000417	CcSEcCtD
Salbutamol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000413	CcSEcCtD
Salbutamol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000412	CcSEcCtD
Salbutamol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.000412	CcSEcCtD
Salbutamol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00041	CcSEcCtD
Salbutamol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00041	CcSEcCtD
Salbutamol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00041	CcSEcCtD
Salbutamol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000408	CcSEcCtD
Salbutamol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000407	CcSEcCtD
Salbutamol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000406	CcSEcCtD
Salbutamol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000405	CcSEcCtD
Salbutamol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000404	CcSEcCtD
Salbutamol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000403	CcSEcCtD
Salbutamol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000399	CcSEcCtD
Salbutamol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000397	CcSEcCtD
Salbutamol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000393	CcSEcCtD
Salbutamol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000391	CcSEcCtD
Salbutamol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000391	CcSEcCtD
Salbutamol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000387	CcSEcCtD
Salbutamol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000387	CcSEcCtD
Salbutamol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000386	CcSEcCtD
Salbutamol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000384	CcSEcCtD
Salbutamol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000384	CcSEcCtD
Salbutamol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000383	CcSEcCtD
Salbutamol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000382	CcSEcCtD
Salbutamol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.000382	CcSEcCtD
Salbutamol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000381	CcSEcCtD
Salbutamol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000372	CcSEcCtD
Salbutamol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000371	CcSEcCtD
Salbutamol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000369	CcSEcCtD
Salbutamol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000368	CcSEcCtD
Salbutamol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000367	CcSEcCtD
Salbutamol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000367	CcSEcCtD
Salbutamol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000365	CcSEcCtD
Salbutamol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000365	CcSEcCtD
Salbutamol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000362	CcSEcCtD
Salbutamol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000357	CcSEcCtD
Salbutamol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000355	CcSEcCtD
Salbutamol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000355	CcSEcCtD
Salbutamol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00035	CcSEcCtD
Salbutamol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000346	CcSEcCtD
Salbutamol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000343	CcSEcCtD
Salbutamol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000343	CcSEcCtD
Salbutamol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00034	CcSEcCtD
Salbutamol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00034	CcSEcCtD
Salbutamol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000339	CcSEcCtD
Salbutamol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000338	CcSEcCtD
Salbutamol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00033	CcSEcCtD
Salbutamol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000327	CcSEcCtD
Salbutamol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000327	CcSEcCtD
Salbutamol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000327	CcSEcCtD
Salbutamol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000325	CcSEcCtD
Salbutamol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00032	CcSEcCtD
Salbutamol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000315	CcSEcCtD
Salbutamol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000312	CcSEcCtD
Salbutamol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000312	CcSEcCtD
Salbutamol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00031	CcSEcCtD
Salbutamol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000308	CcSEcCtD
Salbutamol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000294	CcSEcCtD
